secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2022-08-10T23:59:59+00:00
Accession:  0001005286-22-000029
Event type: other_material
Sentiment:  neutral
Materiality: 0.85
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Landec reports Q4 net loss $35.9M, announces CEO change and rebranding
----------------------------------------------------------------------

- Lifecore segment Q4 revenue $27.6M (+6.9% YoY), adjusted EBITDA $8.9M (+15.9%).
- Consolidated Q4 net loss $35.9M includes $27M non-cash impairment on avocado business.
- Full-year Lifecore revenue $109.3M (+11.5%), adjusted EBITDA $28.9M (+17.9%).
- CEO Albert Bolles transitions to President of Curation Foods; James G. Hall named new CEO.
- Plans to rebrand as Lifecore Biomedical, new ticker LFCR; four directors to step down at 2023 meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528622000029/0001005286-22-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528622000029/lndc-20220808.htm
  HTML page:      https://secwatch.observer/filing/0001005286-22-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer